Drug Shortage Report for CATHFLO
| Report ID | 247639 |
| Drug Identification Number | 02245859 |
| Brand name | CATHFLO |
| Common or Proper name | ALTEPLASE |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ALTEPLASE |
| Strength(s) | 2MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INSTILLATION INSTILLATION |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 2MG VIAL, PACK OF 10 VIALS |
| ATC code | B01AD |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2025-02-24 |
| Estimated end date | 2025-03-14 |
| Actual end date | 2025-03-04 |
| Shortage status | Resolved |
| Updated date | 2025-03-05 |
| Company comments | Normal supply distribution for Cathflo has resumed. If you have any questions regarding Cathflo supply please contact Order and Distribution Management: [email protected]. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.